Public list Medical Devices (6123):
Ignyta, formerly NexDx, specializes in precision medicine and biotechnology, with an integrated Rx/Dx approach in oncology, for the benefit of cancer patients everywhere.
4545 Towne Centre Ct.
San Diego, 92121
California, United States
|Investor||Investor Type||Location||Participating Rounds|
|Title||Application Date||Patent Date||Status
(Patent / Application)
|Bendamustine derivatives and methods of using same||Mar 10, 2017||Mar 13, 2018||Patent|
|Pyrazolo[1,5-a]pyridine derivatives and methods of their use||Dec 18, 2014||Mar 13, 2018||Patent|
|Uracil derivatives as axl and c-met kinase inhibitors||Nov 08, 2016||Aug 29, 2017||Patent|
|Solid state forms of a quinazoline derivative and its use as a braf inhibitor||Apr 25, 2016||Aug 01, 2017||Patent|
|Bendamustine derivatives and methods of using same||Jun 16, 2016||Apr 25, 2017||Patent|